Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use

Major obstetric haemorrhage remains a significant cause of maternal morbidity and mortality. Previous case reports suggest the potential benefit of recombinant activated factor VII (rFVIIa: NovoSeven(R)) as a haemostatic agent. We performed a retrospective review of the use of rVIIa in major obstetr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bomken, Charlotte, Mathai, Sue, Biss, Tina, Loughney, Andrew, Hanley, John
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2009
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2817503/
https://ncbi.nlm.nih.gov/pubmed/20148069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/364843
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares